fbpx
QQQ
+ 0.43
303.42
+ 0.14%
DIA
+ 0.85
298.31
+ 0.28%
SPY
-0.15
366.97
-0.04%
TLT
+ 1.26
154.99
+ 0.81%
GLD
+ 1.27
170.26
+ 0.74%

Leafly, 4Front Ventures, Weedmaps, Others Lobby For Marijuana Descheduling In Wake Of Vaping Crisis

October 3, 2019 12:30 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

More than 800 cannabis companies have signed a letter asking Congress to deschedule marijuana, Marijuana Moment reported Thursday.

The letter submitted to House and Senate leadership Thursday said the vaping situation demands strict federal regulations that are only possible once marijuana is removed from the federal schedule of controlled substances.

The National Cannabis Industry Association was the main driver behind the letter, which also emphasizes that most of the medical issues in question were caused by the use of unregulated products.

“Recent reports of vaping-related illnesses and deaths are alarming and demand an immediate, robust investigation by public health professionals. Make no mistake, the legal state-regulated cannabis industry knows that any death is one death too many. Fortunately, we have policy tools that can be employed to help limit the illicit market, implement uniform good manufacturing practices and prevent future harms, “ the letter said. 

Among those 800 and more signatures are some big names in the industry, such as Leafly, Canopy Rivers Inc (OTC:CNPOF), 4Front Ventures Corp (OTC:FFNTF), Weedmaps, Berkeley Patients Group and SPARC.

"Descheduling cannabis would end many of the federal policies that make it difficult for legal cannabis businesses to effectively compete with illicit operators. Eliminating the undue burdens caused by outdated laws would help ensure that unethical actors are increasingly disrupted by legitimate, responsible businesses,” the companies said. 

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

Aaron Smith, NCIA’s executive director, told Marijuana Moment that “it is absolutely vital for members of Congress to understand that this vaping illness outbreak is directly tied to failed prohibition policies that support the unregulated underground market.”

No illness outbreaks occur due to tainted alcohol because the substance is regulated at the federal and state levels, and licensed producers have almost entirely replaced bootleggers, he said. 

“Descheduling cannabis products and regulating them effectively is essential to improving on successful state regulatory systems, allowing more comprehensive research and displacing the illicit market.”

The letter also outlined several policy recommendations to help consumers stay away from dangerous products, such as advising that licensed vape cartridge producers avoid additive thickening agents, and that those who have been using Vitamin E acetate additive should issue a recall of the products. 

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.


Related Articles

Home Cannabis Cultivation Continues, Despite Opposition From Many Marijuana Companies

Home cultivation has emerged as a clear sticking point in cannabis reform across many states. While it faces pushback, including from several cannabis brands, home grow is making incremental progress in medical and adult use markets, and ushering in a variety of parameters to meet state needs.  read more

PreMarket Prep Stock Of The Day: GW Pharmaceuticals

Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session. read more

Hemp Farm Owner Q. Nicole McNair Wants To Help You Launch Your Own CBD Venture

For those looking to start their own CBD business, real estate investor and hemp farm owner Q. Nicole McNair offers something of a “first aid kit”. More precisely, McNair has launched the CBD Business Launch Kit to help all individuals interested in developing their own CBD business. read more

The 420 Investor, Alan Brochstein, To Interview On Benzinga's PreMarket Prep At 8:35 a.m. EST Thursday

https://www.youtube.com/c/Benzinga/videos read more

InMed Licenses MiDROPS Delivery Technology From EyeCRO For Delivery Of Therapeutic Cannabinoids

- Initial application with INM-088 to treat ocular disease - VANCOUVER, BC, Dec. 3, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM) read more